189 related articles for article (PubMed ID: 19293153)
1. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
LaChapelle S; Tweten RK; Hotze EM
J Biol Chem; 2009 May; 284(19):12719-26. PubMed ID: 19293153
[TBL] [Abstract][Full Text] [Related]
2. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.
Johnson S; Brooks NJ; Smith RA; Lea SM; Bubeck D
Cell Rep; 2013 May; 3(5):1369-77. PubMed ID: 23665225
[TBL] [Abstract][Full Text] [Related]
4. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
Soltani CE; Hotze EM; Johnson AE; Tweten RK
J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
[TBL] [Abstract][Full Text] [Related]
5. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
Hughes TR; Ross KS; Cowan GJ; Sivasankar B; Harris CL; Mitchell TJ; Morgan BP
Mol Immunol; 2009 Apr; 46(7):1561-7. PubMed ID: 19200600
[TBL] [Abstract][Full Text] [Related]
6. Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
Boyd CM; Parsons ES; Smith RA; Seddon JM; Ces O; Bubeck D
Sci Rep; 2016 Dec; 6():38446. PubMed ID: 27910935
[TBL] [Abstract][Full Text] [Related]
7. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
8. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
Zilnyte M; Venclovas Č; Zvirbliene A; Pleckaityte M
Toxins (Basel); 2015 Jan; 7(1):110-28. PubMed ID: 25590277
[TBL] [Abstract][Full Text] [Related]
9. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
Drabavicius G; Daelemans D
PLoS Genet; 2021 Feb; 17(2):e1009387. PubMed ID: 33577603
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
11. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
12. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
Giddings KS; Zhao J; Sims PJ; Tweten RK
Nat Struct Mol Biol; 2004 Dec; 11(12):1173-8. PubMed ID: 15543155
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
14. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
Slade DJ; Chiswell B; Sodetz JM
Biochemistry; 2006 Apr; 45(16):5290-6. PubMed ID: 16618117
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
16. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.
Polekhina G; Giddings KS; Tweten RK; Parker MW
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):600-5. PubMed ID: 15637162
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for membrane attack complex inhibition by CD59.
Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
[TBL] [Abstract][Full Text] [Related]
18. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
19. Membrane pore formation by human complement: functional importance of the transmembrane β-hairpin (TMH) segments of C8α and C9.
Weiland MH; Qian Y; Sodetz JM
Mol Immunol; 2014 Feb; 57(2):310-6. PubMed ID: 24239861
[TBL] [Abstract][Full Text] [Related]
20. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
